Uncoupling Protein Polymorphisms in Metabolic Disorders

Uncoupling proteins (UCPs) are integral carriers in the mitochondrial inner membrane that dissipate the proton gradient to regulate heat production and control reactive oxygen species. Genetic variations in UCP1, UCP2 and UCP3, notably single nucleotide polymorphisms (SNPs) in promoter or coding regions, can alter protein expression and function. Such polymorphisms modulate energy expenditure, insulin secretion, lipid oxidation and cellular redox balance, thereby influencing susceptibility to obesity, type 2 diabetes and vascular complications. Common variants—such as UCP1 A-3826G, UCP2 ‑866G/A and Ala55Val, and UCP3 ‑55C/T—exhibit population-specific allele frequencies and gene–environment interactions that account for divergent results across ethnic groups. Mechanistic studies reveal that UCP2 upregulation in pancreatic β-cells can protect against oxidative stress but may impair insulin output when overexpressed, while UCP1 activity in brown adipose tissue underlies adaptive thermogenesis. Emerging evidence also implicates UCP dysregulation in hepatic inflammation, immune cell viability and renal complications in diabetes. Elucidating the functional consequences of UCP polymorphisms offers opportunities for risk stratification and personalised interventions, including dietary modulation and small-molecule inducers or inhibitors of UCP expression. Despite advances, challenges remain in translating genetic associations into clinical practice, owing to variable penetrance, interacting loci and the need for large-scale, multi-ethnic validation. A comprehensive understanding of UCP gene variants thus holds promise for novel strategies to prevent and manage metabolic disorders on a global scale.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Uncoupling Protein Polymorphisms in Metabolic Disorders publication trend

The graph below shows the total number of articles in uncoupling protein polymorphisms in metabolic disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Uncoupling protein (UCP): A mitochondrial inner-membrane carrier that dissipates the proton gradient to generate heat rather than ATP, regulating energy expenditure and oxidative stress.

Single nucleotide polymorphism (SNP): A single base-pair change in the genome that can affect gene expression or protein function and contribute to individual variation in disease risk.

Thermogenesis: The process of heat production in organisms, largely mediated by UCP1 in brown adipose tissue to maintain body temperature and energy balance.

Mitochondrial membrane potential: The electric potential difference across the mitochondrial inner membrane, driving ATP synthesis and regulated by proton leak through UCPs.

Necroptosis: A form of programmed cell death with features of necrosis and apoptosis, triggered by metabolic stress and implicating mitochondrial dysfunction.

Nonalcoholic steatohepatitis (NASH): An inflammatory liver disease characterised by fat accumulation, hepatocellular injury and fibrosis in the absence of significant alcohol intake.

References

1. Decrease in UCP1 by sustained high lipid promotes NK cell necroptosis to exacerbate nonalcoholic liver fibrosis. Cell Death & Disease (2024).
2. ACOT1 deficiency attenuates high-fat diet induced fat mass gain by increasing energy expenditure. JCI Insight (2023).
3. Association of uncoupling protein (Ucp) gene polymorphisms with cardiometabolic diseases. Molecular Medicine (2020).
4. Associations between UCP1 -3826A/G, UCP2 -866G/A, Ala55Val and Ins/Del, and UCP3 -55C/T Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus: Case-Control Study and Meta-Analysis. PLOS ONE (2013).